West Virginia prescription drug program showing growth, success within first three months

NewsGuard 100/100 Score

West Virginia Rx, a new state-managed prescription drug program that allows uninsured state residents to obtain medications at no cost, is on track to enroll 10,000 people within its first year, the Charleston Gazette reports (Kabler, Charleston Gazette, 7/17).

Uninsured residents between ages 18 and 65 with annual incomes less than 200% of the federal poverty level are eligible to purchase the drugs, which are donated by pharmaceutical companies (Kaiser Daily Health Policy Report, 4/1).

Each resident must pay a $30 annual processing fee.

About 200 people signed up for the program when it was launched, but it has grown quickly through a Web site that allows physicians to enroll patients in about one minute, according to program Director Barbara Dane.

She said the program could fill about 50,000 prescriptions in its first year at an estimated value of $7.5 million.

Dane said the objective of the program is to provide uninsured state residents with an affordable way to get their prescription medications, instead of seeking care at state charity hospitals. She said, "Even a minimal impact promises to save millions of dollars" (Charleston Gazette, 7/17).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Special drug-pricing program boosts prostate cancer treatment adherence